How would you approach treatment selection for an elderly woman with de novo metastatic HER2+ breast cancer with lung and brain mets?
Would ER positivity change your choice?
1 Answer
Mednet MemberInvited Expert
Medical Oncology · University of Pittsburgh School of Medicine
Answered on
This depends on performance status. For good PS, T-DXd. For poorer PS, T-DM1. I would consider SRS if needed for the brain mets.
Join for free or sign in to see the full answer